The changing landscape of European and international regulation on embryonic stem cell research.
Legislation in individual member states of the European Union on human embryonic stem cell (hESC) research is as divergent as the different cultural, ethical, and religious views on the issue. On the occasion of the public launch of the European Human Embryonic Stem Cell Registry (hESCreg: www.hescreg.eu), a two-day symposium was held on 18 and 19 January 2008 in Berlin to offer participants an overview of state-of-the-art hESC research and legislation throughout Europe and in selected regions of the world. Thirty leading scientists from Europe as well as from the United States, Japan, and Australia reported on a range of aspects related to research on hESC and reviewed the key elements of the newly established hESCreg database of hESC lines. In this article we summarize and complete the information on the current status of international hESC regulation.
Elstner
A
A
Cell Therapy Group, Berlin-Brandenburg Center for Regenerative Therapies, Charité-Universitätsmedizin, Berlin, Germany.
Damaschun
A
A
Kurtz
A
A
Stacey
G
G
Arán
B
B
Veiga
A
A
Borstlap
J
J
D001315:Australia; D001675:Bioethics / Q000639:trends; D035843:Biomedical Research / Q000331:legislation & jurisprudence* / Q000639:trends; D002460:Cell Line; D016208:Databases, Factual; D053595:Embryonic Stem Cells; D005060:Europe; D006801:Humans; D038622:Internationality / Q000331:legislation & jurisprudence; D007564:Japan; D007878:Legislation as Topic; D014481:United States